ACLOVATE (alclometasone dipropionate) by Sandoz is clinical pharmacology like other topical corticosteroids, alclometasone dipropionate has anti-inflammatory, antipruritic, and vasoconstrictive properties. First approved in 1982.
Drug data last refreshed Yesterday
ACLOVATE (alclometasone dipropionate) is a low-to-medium potency topical corticosteroid ointment approved in 1982 for inflammatory skin conditions. It treats eczema, psoriasis, pruritus, and allergic dermatitis by inducing lipocortin proteins that inhibit prostaglandin and leukotriene synthesis, reducing inflammation and itching. Approximately 3% systemic absorption occurs with intact skin contact, making it suitable for localized dermatological use.
Product approaching loss of exclusivity with moderate competitive pressure (30/100) signals defensive positioning and potential consolidation within Sandoz's dermatology portfolio.
CLINICAL PHARMACOLOGY Like other topical corticosteroids, alclometasone dipropionate has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on ACLOVATE at Sandoz? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream
Working on ACLOVATE offers limited growth opportunity and a smaller, more specialized team focused on defending market share against generics and newer systemic competitors. Career progression is best suited to professionals interested in mature portfolio management, market access strategy, and cost-containment innovation rather than product launch or rapid expansion.